Full text is available at the source.
FMO3 and its metabolite TMAO contribute to the formation of gallstones
FMO3 and its product TMAO may contribute to gallstone formation
AI simplified
Abstract
High plasma TMAO levels were positively associated with gallstone disease in humans.
- TMAO is produced from trimethylamine by gut bacteria and further oxidized in the liver.
- Increased hepatic expression of FMO3 and elevated plasma TMAO levels were observed in gallstone-susceptible mice fed a lithogenic diet.
- Dietary TMAO or its precursor choline may increase hepatic FMO3 expression and plasma TMAO levels.
- Supplementation with TMAO led to a 70% incidence of gallstones in gallstone-resistant mice on a lithogenic diet.
- Increased expression of cholesterol transporters Abcg5 and Abcg8 in the liver is associated with TMAO treatment.
AI simplified